Mecamylamine - Targacept

Drug Profile

Mecamylamine - Targacept

Alternative Names: Inversine; TRIDMAC

Latest Information Update: 28 May 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Merck & Co; Targacept
  • Developer Targacept
  • Class Eye disorder therapies; Norbornanes; Small molecules
  • Mechanism of Action Nicotinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Market Withdrawal Hypertension
  • Discontinued Attention-deficit hyperactivity disorder; Major depressive disorder

Most Recent Events

  • 30 Sep 2009 Withdrawn for Hypertension in USA (PO)
  • 30 Oct 2007 Discontinued - Phase-II for Depression in India (PO)
  • 30 Oct 2007 Discontinued - Phase-II for Depression in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top